AFM1 exposure in male balb/c mice and intervention strategies against its immuno-physiological toxicity using clay mineral and lactic acid bacteria alone or in combination.

IF 2.9 4区 医学 Q3 IMMUNOLOGY
Amina Aloui, Jalila Ben Salah-Abbès, Hela Belgacem, Haifa Dhif, Abdellah Zinedine, Amar Riba, Jean Christophe Meile, Noel Durande, Catherine Brabet, Samir Abbès
{"title":"AFM<sub>1</sub> exposure in male balb/c mice and intervention strategies against its immuno-physiological toxicity using clay mineral and lactic acid bacteria alone or in combination.","authors":"Amina Aloui, Jalila Ben Salah-Abbès, Hela Belgacem, Haifa Dhif, Abdellah Zinedine, Amar Riba, Jean Christophe Meile, Noel Durande, Catherine Brabet, Samir Abbès","doi":"10.1080/08923973.2023.2300299","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Aflatoxins are the most harmful mycotoxins that cause human and animal health concerns. Aflatoxin M<sub>1</sub> (AFM<sub>1</sub>) is the primary hydroxylated metabolite of aflatoxin B<sub>1</sub> and is linked to the development of hepatocellular carcinoma and immunotoxicity in humans and animals. Because of the important role of dairy products in human life, especially children, AFM<sub>1</sub> is such a major concern to humans because of its frequent occurrence in dairy products at concentrations high enough to cause adverse effects to human and animal health. Reduced its bioavailability becomes a high priority in order to protect human and animal health.</p><p><strong>Objectives: </strong>This study aimed to investigate, <i>in vivo</i>, the ability of lactic acid bacteria (<i>lactobacillus rhamnosus</i> GAF01, LR) and clay mineral (bentonite, BT) mixture to mitigate/reduce AFM<sub>1</sub>-induced immunotoxicity, hepatotoxicity, nephrotoxicity and oxidative stress in exposed Balb/c mice.</p><p><strong>Materials and methods: </strong>The <i>in vivo</i> study was conducted using male Balb/c mice that treated, orally, by AFM<sub>1</sub> alone or in combination with LR and/or BT, daily for 10 days as follows: group 1 control received 200 µl of PBS, group 2 treated with LR alone (2.10<sup>8</sup> CFU/mL), group 3 treated with BT alone (1 g/kg bw), group 4 treated with AFM<sub>1</sub> alone (100 μg/kg), group 5 co-treated with LR + AFM<sub>1</sub>, group 6 co-treated with BT + AFM<sub>1</sub>, group 7 co-treated with BT + LR + AFM<sub>1</sub>. Forty-eight h after the end of the treatment, the mice were sacrificed and the blood, spleen, thymus, liver and kidney were collected. The blood was used for biochemical and immunological study. Spleen and thymus samples were used to thymocytes and splenocytes assessments. Liver and kidney samples were the target for evaluation of oxidative stress enzymes status and for histological assays.</p><p><strong>Results: </strong>The results showed that AFM<sub>1</sub> caused toxicities in male Blab/c mice at different levels. Treatment with AFM<sub>1</sub> resulted in severe stress of liver and kidney organs indicated by a significant change in the biochemical and immunological parameters, histopathology as well as a disorder in the profile of oxidative stress enzymes levels. Also, it was demonstrated that AFM<sub>1</sub> caused toxicities in thymus and spleen organs. The co-treatment with LR and/or BT significantly improved the hepatic and renal tissues, regulated antioxidant enzyme activities, spleen and thymus viability and biochemical and immunological parameters. LR and BT alone showed to be safe during the treatment.</p><p><strong>Conclusion: </strong>In summary, the LR and/or BT was able to reduce the biochemical, histopathological and immunological damages induced by AFM<sub>1</sub> and indeed it could be exploited as one of the biological strategies for food and feedstuffs detoxification.</p>","PeriodicalId":13420,"journal":{"name":"Immunopharmacology and Immunotoxicology","volume":" ","pages":"199-211"},"PeriodicalIF":2.9000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunopharmacology and Immunotoxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08923973.2023.2300299","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/11 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Aflatoxins are the most harmful mycotoxins that cause human and animal health concerns. Aflatoxin M1 (AFM1) is the primary hydroxylated metabolite of aflatoxin B1 and is linked to the development of hepatocellular carcinoma and immunotoxicity in humans and animals. Because of the important role of dairy products in human life, especially children, AFM1 is such a major concern to humans because of its frequent occurrence in dairy products at concentrations high enough to cause adverse effects to human and animal health. Reduced its bioavailability becomes a high priority in order to protect human and animal health.

Objectives: This study aimed to investigate, in vivo, the ability of lactic acid bacteria (lactobacillus rhamnosus GAF01, LR) and clay mineral (bentonite, BT) mixture to mitigate/reduce AFM1-induced immunotoxicity, hepatotoxicity, nephrotoxicity and oxidative stress in exposed Balb/c mice.

Materials and methods: The in vivo study was conducted using male Balb/c mice that treated, orally, by AFM1 alone or in combination with LR and/or BT, daily for 10 days as follows: group 1 control received 200 µl of PBS, group 2 treated with LR alone (2.108 CFU/mL), group 3 treated with BT alone (1 g/kg bw), group 4 treated with AFM1 alone (100 μg/kg), group 5 co-treated with LR + AFM1, group 6 co-treated with BT + AFM1, group 7 co-treated with BT + LR + AFM1. Forty-eight h after the end of the treatment, the mice were sacrificed and the blood, spleen, thymus, liver and kidney were collected. The blood was used for biochemical and immunological study. Spleen and thymus samples were used to thymocytes and splenocytes assessments. Liver and kidney samples were the target for evaluation of oxidative stress enzymes status and for histological assays.

Results: The results showed that AFM1 caused toxicities in male Blab/c mice at different levels. Treatment with AFM1 resulted in severe stress of liver and kidney organs indicated by a significant change in the biochemical and immunological parameters, histopathology as well as a disorder in the profile of oxidative stress enzymes levels. Also, it was demonstrated that AFM1 caused toxicities in thymus and spleen organs. The co-treatment with LR and/or BT significantly improved the hepatic and renal tissues, regulated antioxidant enzyme activities, spleen and thymus viability and biochemical and immunological parameters. LR and BT alone showed to be safe during the treatment.

Conclusion: In summary, the LR and/or BT was able to reduce the biochemical, histopathological and immunological damages induced by AFM1 and indeed it could be exploited as one of the biological strategies for food and feedstuffs detoxification.

雄性 Balb/c 小鼠的 AFM1 暴露以及单独或联合使用粘土矿物和乳酸菌对抗其免疫生理毒性的干预策略。
背景:黄曲霉毒素是对人类和动物健康危害最大的霉菌毒素。黄曲霉毒素 M1(AFM1)是黄曲霉毒素 B1 的主要羟化代谢产物,与人类和动物肝细胞癌和免疫毒性的发生有关。由于乳制品在人类(尤其是儿童)的生活中扮演着重要角色,AFM1 成为人类关注的焦点,因为它经常出现在乳制品中,其浓度之高足以对人类和动物的健康造成不良影响。为了保护人类和动物的健康,降低其生物利用率成为当务之急:本研究旨在调查乳酸菌(鼠李糖乳杆菌 GAF01,LR)和粘土矿物(膨润土,BT)混合物在暴露于 AFM1 的 Balb/c 小鼠体内减轻/降低 AFM1 引起的免疫毒性、肝毒性、肾毒性和氧化应激的能力:体内研究使用雄性 Balb/c 小鼠,每天口服单独或与 LR 和/或 BT 混合的 AFM1,连续 10 天,具体如下:第 1 组对照接受 200 µl PBS,第 2 组单独接受 LR(2.108 CFU/mL),第 3 组单独用 BT 处理(1g/kg 体重),第 4 组单独用 AFM1 处理(100 μg/kg),第 5 组联合用 LR + AFM1 处理,第 6 组联合用 BT + AFM1 处理,第 7 组联合用 BT + LR + AFM1 处理。治疗结束 48 小时后,小鼠被处死,收集血液、脾脏、胸腺、肝脏和肾脏。血液用于生化和免疫学研究。脾脏和胸腺样本用于胸腺细胞和脾脏细胞评估。肝脏和肾脏样本用于评估氧化应激酶状态和组织学检测:结果表明,AFM1 会对雄性 Blab/c 小鼠造成不同程度的毒性。用 AFM1 治疗导致肝脏和肾脏器官严重受损,表现为生化和免疫学参数、组织病理学的显著变化以及氧化应激酶水平的紊乱。此外,AFM1 还对胸腺和脾脏器官造成毒性。与 LR 和/或 BT 联合治疗可明显改善肝脏和肾脏组织,调节抗氧化酶活性、脾脏和胸腺活力以及生化和免疫学参数。单独使用 LR 和 BT 在治疗期间是安全的:总之,LR 和/或 BT 能够减轻 AFM1 引起的生化、组织病理学和免疫学损伤,因此可将其作为食品和饲料解毒的生物策略之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.40
自引率
0.00%
发文量
133
审稿时长
4-8 weeks
期刊介绍: The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal. The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome. With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more. Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信